Northern Light Leads $25M Series B Round In TenNor Therapeutics

This Data Is Locked!

This area is available only to Subscribers.

Northern Light Venture Capital has led a US$25 million series B round of financing in TenNor Therapeutics, a clinical stage company focused on developing dual-acting... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?